The interior of a regenerating lizard tail 14 days after the original tail was amputated. Cell nuclei (blue), proliferating cells (green), cartilage (red), and muscle (white) have been visualized with immunofluorescence staining.

Glide across an icy canyon, where you see smiling snowmen and waddling penguins. Toss a snowball, hear it smash against an igloo, and then watch it explode in bright colors. Psychologists David Patterson and Hunter Hoffman of the University of Washington in Seattle developed this virtual "Snow World" to test whether immersing someone in a pretend reality could ease pain during burn treatment and other medical procedures. They found that people fully engaged in the virtual reality experience reported 60 percent less pain. The technology offers a promising way to manage pain.

A cross section of the measles virus in which six proteins (enlarged on the outside of the virus) work together to infect cells. The measles virus is extremely infectious; 9 out of 10 people exposed will contract the disease. Fortunately, an effective vaccine protects against infection. Portions of the proteins that have not been determined are shown with dots.

Learn more about the six proteins on PDB 101’s Molecule of the Month: Measles Virus Proteins. Structures are available for the ordered regions of nucleoprotein and phosphoprotein (PDB entries 5E4V, 3ZDO, 1T6O), but the remaining regions are thought to form a flexible, random tangle. For a larger look at the measles virus, see 6995.

These neurons are derived from mouse embryonic stem cells. Red shows cells making a protein called TH that is characteristic of the neurons that degenerate in Parkinson's disease. Green indicates a protein that's found in all neurons. Blue indicates the nuclei of all cells. Studying dopaminergic neurons can help researchers understand the origins of Parkinson's disease and could be used to screen potential new drugs. Image and caption information courtesy of the California Institute for Regenerative Medicine. Related to images 3270 and 3285.

Scientists revealed a detailed image of the genetic defect that causes myotonic dystrophy type 2 and used that information to design drug candidates to counteract the disease.